Stonepine Capital Management, LLC Heron Therapeutics, Inc. Transaction History
Stonepine Capital Management, LLC
- $102 Billion
- Q2 2025
A detailed history of Stonepine Capital Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 657,380 shares of HRTX stock, worth $861,167. This represents 1.34% of its overall portfolio holdings.
Number of Shares
657,380
Previous 796,100
17.42%
Holding current value
$861,167
Previous $1.75 Billion
22.3%
% of portfolio
1.34%
Previous 1.7%
Shares
3 transactions
Others Institutions Holding HRTX
# of Institutions
185Shares Held
130MCall Options Held
1.56MPut Options Held
27.1K-
Rubric Capital Management LP New York, NY26.7MShares$35 Million1.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.47MShares$11.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$10.9 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$10.3 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$9.15 Million24.86% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $156M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...